Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.67
Delayed Data
As of Sep 01
 0.00 / 0.00%
Today’s Change
3.79
Today|||52-Week Range
12.55
+43.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-32.8M-67.3M-65.8M-135.6M
 
 
 
 
 
Depreciation10.0K14.0K11.0K11.0K
 
 
 
 
 
Total Other Cash Flow16.0M28.9M13.5M57.0M
 
 
 
 
 
Funds From Operations-16.8M-38.4M-52.3M-78.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.1M-15.6M-14.5M-24.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.7M-22.8M-37.8M-54.6M
 
 
 
 
 
 
InvestingCapital Expenditures-49.0K-31.0K---33.7M
 
 
 
 
Fixed Asset Disposal0.000.001.0K--
 
 
Other Investing - Uses0.000.000.00-2.6M
 
 
Net Cash Flow Investing-49.0K-31.0K1.0K-36.4M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings10.0M13.2M-2.3M24.5M
 
 
 
 
 
Long Term Debt Reduction-849.0K-2.2M-2.3M-25.0K
 
 
 
 
 
Net Proceeds Stock Sale5.5M19.2M53.6M63.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.001.9M
 
 
Net Cash Flow - Financing14.6M30.1M49.0M85.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash3.0K-40.0K0.000.00
 
 
 
 
Net Change In Cash-132.0K7.4M11.2M-5.1M